Autopsy report · NCT00767039

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

“Slow recruitment,changes in protocols, larger than anticipated differences”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 11 months after it had already started.
• Ran for about 4 years before it stopped.
• 52 participants enrolled.
• Results were posted on the registry 2 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Alan Fujii

Sponsor type

University, hospital or other

Conditions

Prematurity; Respiratory Distress Syndrome; Patent Ductus Arteriosus

Interventions

Survanta (beractant); Curosurf (poractant)

Participants

52

Sites

1

Countries

United States

Trials that died the same way

• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (82% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (81% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (81% match in meaning)
• PReventing the EffectS of Intubation on DEglutition
  “slow recruitment” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.